BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16273005)

  • 1. [Role of pemetrexed given with radiotherapy].
    Mornex F
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S18-9. PubMed ID: 16273005
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
    Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].
    Pérol M
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S14-7. PubMed ID: 16273004
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemetrexed disodium for the treatment of NSCLC: an update.
    Hsu JY; Wakelee H
    Drugs Today (Barc); 2008 Sep; 44(9):669-78. PubMed ID: 19137122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
    [No Abstract]   [Full Text] [Related]  

  • 6. Pemetrexed and maintenance therapy for non-small cell lung cancer.
    Prescrire Int; 2011 Feb; 20(113):39. PubMed ID: 21488588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Update of pemetrexed in thoracic oncology].
    Brechot JM; Morère JF
    Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer.
    Bogart JA; Govindan R
    Clin Lung Cancer; 2006 Jan; 7(4):285-7. PubMed ID: 16512986
    [No Abstract]   [Full Text] [Related]  

  • 10. Pemetrexed-induced eyelid edema: incidence and clinical manifestations.
    Schallier D; Decoster L; Fontaine C; De Grève J
    Anticancer Res; 2010 Dec; 30(12):5185-8. PubMed ID: 21187510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial pneumonitis after treatment with pemetrexed: a rare event?
    Hochstrasser A; Benz G; Joerger M; Templeton A; Brutsche M; Früh M
    Chemotherapy; 2012; 58(1):84-8. PubMed ID: 22377772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pemetrexed in lung cancer.
    Wang D; He J
    Curr Drug Targets; 2010 Jan; 11(1):1. PubMed ID: 20017724
    [No Abstract]   [Full Text] [Related]  

  • 13. Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.
    Ferraldeschi R; Thatcher N; Lorigan P
    Expert Rev Anticancer Ther; 2007 May; 7(5):635-40. PubMed ID: 17492928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial.
    Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of pemetrexed on brain metastases from non-small cell lung cancer: what is the mechanism?
    Dogan M; Yalcin B; Utkan G; Urun Y; Ozal G
    Lung Cancer; 2009 Dec; 66(3):399. PubMed ID: 19783320
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
    Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
    Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
    Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
    Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pemetrexed in non-small cell lung cancer.
    Longo-Sorbello GS; Chen B; Budak-Alpdogan T; Bertino JR
    Cancer Invest; 2007 Feb; 25(1):59-66. PubMed ID: 17364559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.